Across the trailing ten quarters ROIC ranged from 14.4% to a peak of 26.3% in 2025Q4, a level consistent with a royalty-heavy franchisor earning high returns on a thin invested-capital base. The 5.5% print coincides with the $3.5B debt retirement and the equity rebuild from -$4.0B toward -$2.1B, which may have inflated the invested-capital denominator; analysts should verify the calculation basis before treating this as a structural return decay. If the normalization holds, the historical thesis that DPZ compounds at high-teens returns would need to be re-tested against a de-levered capital structure.

Gross margin expanded roughly 100 basis points from the 39.2% level of 2024Q3, but the sharper move is in operating margin from 17.9% to 20.4%, driven by SG&A falling from 21.7% to 19.8% of revenue — evidence that corporate costs are scaling against a growing royalty stream. Net margin, however, oscillated between 11.4% and 13.6% throughout, so operating margin is the cleaner read on true earning power given interest expense distortions below the line. The Q2 2026 EPS miss ($4.07 versus $4.40 expected) against this backdrop suggests the pressure sat in non-operating items or below-the-line charges rather than in the unit economics.

Interest coverage had fluctuated in a narrow 3.91x–5.22x band for nine consecutive quarters, consistent with a debt load serviced comfortably but consuming a real share of earnings; the current 5.22x sits at the top of that range even as EBITDA presumably grew, so the improvement looks leverage-driven rather than earnings-driven. A $3.5B single-quarter reduction is a large, atypical move for this issuer, and given that buybacks and dividends consumed roughly $1.55B over ten quarters, sustaining this trajectory without a corresponding FCF increase (~$636M TTM) would imply either an asset sale, an equity issuance, or a deliberate pause in the recap program. Investors should watch whether leverage re-rises toward historical norms if the buyback engine restarts.

Sub-unity readings are not new here — the current ratio printed 0.56–0.60 in 2024Q4 through 2025Q2 — which suggests a recurring working-capital pattern in supply-chain payables timing rather than acute distress, though the 0.49 print does sit below that prior floor. The near-tracking of the quick ratio to the current ratio confirms minimal inventory dependence (DIO of only 10 days), so the liquidity profile hinges almost entirely on payables management and cash generation rather than inventory monetization. Under severe stress, the 5.22x interest coverage, ~$636M TTM free cash flow, and a 12.3% FCF margin appear to provide meaningful cushion, but the negative equity base (-$2.1B) removes the traditional balance-sheet backstop that would normally reassure creditors.

The P/E discount to MCD and YUM is not obviously generous when measured against growth: DPZ's PEG of 2.33 versus MCD's 1.46 and YUM's 1.94 suggests the market is already charging more per unit of earnings growth for DPZ, arguably justified by its superior operating-margin trajectory but vulnerable if revenue growth stays near 3.4%. Against the closest operational peer, PZZA at 9.31x EV/EBITDA and a 1.5% net margin, DPZ's premium looks structural — the ROIC gap (historically 15–26% versus PZZA's 11.7%) is the rationale — but that premium narrows considerably if the 5.5% Q3 ROIC proves to be the new baseline rather than an accounting artifact. The 2.3% dividend yield and 14.58x P/FCF round out a valuation that prices durability rather than acceleration, consistent with a business whose EPS growth has leaned on share count reduction rather than revenue compounding.